Semaglutide Research Overview
- Popular Name
- GLP-1 Receptor Agonist
- Category
- Weight Loss & Metabolism
- Evidence Tier
- Approved Drug
- Class
- GLP-1 receptor agonist; fatty-acid conjugated 31-amino-acid peptide analog of human GLP-1
- Primary Target
- GLP-1 receptor (GLP1R); cAMP/PKA signaling; pancreatic beta-cell insulin secretion; hypothalamic appetite suppression; gastric emptying delay
- Half-Life
- ~1 week
- PubMed Citations
- 5,205
- Active Trials
- 399
Mechanism Of Action
It is a GLP-1 receptor agonist that slows gastric emptying and sends strong satiety signals to the hypothalamus, drastically reducing caloric intake and managing insulin release.
Studied For
Type 2 diabetes managementChronic weight management / obesityCardiovascular risk reductionHbA1c loweringAppetite suppressionBody weight reductionNon-alcoholic fatty liver disease (NAFLD/MASH)Kidney disease in diabetes (SELECT trial)
Sourcing Semaglutide In The Northwest Indiana area
Pep Nation Lab supplies research-grade Semaglutide to verified researchers across Valparaiso, IN, in Porter County and the wider Northwest Indiana area. Every Semaglutide order ships nationwide with full batch COA documentation, strictly for in vitro laboratory use.
- Service Area
- Valparaiso, IN (Northwest Indiana)
- County
- Porter County, Indiana
- ZIP Codes Served
- 46383, 46385
- Shipping
- Nationwide To All 50 States, Including Indiana
- Compound
- Semaglutide (GLP-1 Receptor Agonist)
- Documentation
- Batch COA Included With Every Order
- Intended Use
- In Vitro Laboratory Research Only
Semaglutide In Valparaiso - Common Questions
More Research Compounds In Valparaiso
BPC-157 In ValparaisoTB-500 In ValparaisoTirzepatide In ValparaisoRetatrutide In ValparaisoAll Peptides In Valparaiso›
Semaglutide In Nearby Cities

